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Abstract: Granting the association of lactates with mortality has been largely 
documented in critically ill patients with sepsis, its association with the develop-
ment of acute kidney injury (AKI) in this setting is not well established. We aimed 
to analyze the association of serum lactates at intensive care unit (ICU) admission 
with the occurrence AKI in a cohort of critically ill septic patients. Materials and 
methods: This study is retrospective including 457 adult patients with sepsis ad-
mitted to the Division of Intensive Medicine of the Centro Hospitalar Lisboa Norte 
(Lisbon, Portugal) between January 2008 and December 2014. The Kidney Disease 
Improving Global Outcomes (KDIGO) classification was used to diagnose and clas-
sify patients developing AKI within the first week of hospitalization. Logistic regres-
sion analysis was employed to determine factors associated with AKI development. 
Data were expressed as odds ratios (ORs) with 95% confidence intervals (CIs). 
Statistical significance was defined as a p-value < 0.05. Results: AKI occurred in 
87.5% of patients with a maximum KDIGO category (19.5% with stage 1, 22.6% with 
stage 2 and 45.4% with stage 3). Serum lactates were higher among patients de-
veloping AKI as compared with non-AKI patients (mmol/L 29.9 ± 25.7 vs. 18.6 ± 9.3, 
p = 0.001; unadjusted OR 1.04 (95% CI 1.02–1.07), p = 0.001; adjusted OR 1.03 (95% 
CI 1.01–1.06), p = 0.024), and they were progressively higher in accordance with AKI 
severity (stage 1, 24.5 ± 18.7; stage 2, 25.5 ± 16.9; stage 3, 34.6 ± 30.7; p = 0.001). 
Conclusions: Serum lactates at ICU admission were independently associated with 
the occurrence of AKI in critically ill patients with sepsis.
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problem in patients hospitalized, but especially in 
the intensive care unit (ICU). Serum lactate, often 
elevated in this context, is assumed in current 
knowledge as an important form of monitoring 
and prognostic importance in critically ill patients. 
Although physiologically interrelation with the 
kidney, its role as a risk factor for AKI has not been 
studied very sparingly. Therefore, we analyze the 
impact of serum lactates on the occurrence of AKI 
in a cohort of critically ill septic patients, and we 
find that serum lactates at ICU admission were 
independently associated with the occurrence of 
AKI. This finding may make it possible to identify 
these patients earlier.
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1. Introduction
The primary cause of acute kidney injury (AKI) in intensive care units (ICU) is sepsis. It is well known 
that those patients suffering non-septic AKI are clinically different from those with AKI of septic ori-
gin. In reality, septic AKI is linked to higher disease severity scores at admission into the ICU, an in-
creased necessity for vasoactive drugs, non-renal organ failure, requirement for mechanical 
ventilation, extended ICU and hospital stay, increased in-hospital mortality and a higher probability 
of recovery of renal function at discharge from hospital (Bagshaw et al., 2007; Uchino et al., 2005). 
Consequently, it is crucial that both the nephrologist and the intensivist display a deep understand-
ing and purview of septic AKI, not only as a means to ensure correct diagnoses, but also to aid in 
fundamental treatment decisions, follow-up strategies and, ultimately, assist in the prediction of 
patient outcome.
Serum lactate has been widely considered as an important biomarker for the evaluation of hemo-
dynamic status in the critically ill patient. Since lactate is a sensitive biomarker of global and regional 
hypoperfusion, lactate can be used as a marker of ongoing hypoperfusion that may contribute to 
continuing development of AKI (Zhang & Ni, 2015). Despite the fact that the deleterious impact of 
raised serum lactates on mortality has been broadly reported in critically ill septic patients (Moskowitz 
et al., 2016; Singer et al., 2016), the association of serum lactates with the development of AKI in 
sepsis is still not well defined.
The purpose of this study was to analyze the association of serum lactates at ICU admission with 
the occurrence of AKI in a cohort of critically ill patients admitted to this department with a diagno-
sis of sepsis. To achieve this aim, we cross-examined data from a retrospective study in which we 
studied a cohort of critically ill patients admitted with sepsis to the ICU and in which the primary 
objective was to compare the diagnostic sensitivity and prognostic ability of the standard classifica-
tions for AKI, namely the ‘Risk, Injury, Failure, Loss of kidney function, End-stage kidney disease’ 
(RIFLE), Acute Kidney Injury Network (AKIN) and Kidney Disease: Improving Global Outcomes 
(KDIGO) classifications (Pereira et al., 2016).
2. Methods
This study is retrospective in nature and inclusive of all patients with sepsis admitted between 
January 2008 and December 2014 to the Division of Intensive Medicine of the Centro Hospitalar 
Lisboa Norte (Lisbon, Portugal), an academic and referral center serving a population of 3,000,000 
inhabitants.
2.1. Participants
All eligible patients were selected by consultation of the ICU patient admission register. Adult pa-
tients (≥18 years of age) with a diagnosis of sepsis at admission to the Division of Intensive Medicine 
were included. Sepsis was defined by current criteria in agreement with the third international con-
sensus definitions for sepsis and septic shock (Singer et al., 2016). Exclusion criteria were clearly 
defined and encompassed the following: (i) chronic kidney disease (CKD) patients already on renal 
replacement therapy; (ii) patients who required and underwent renal replacement therapy one week 
prior to admission to the ICU; and (iii) patients who were discharged or died less than two days after 
ICU admission.
2.2. Variables and data sources
Patient variables were collected from individual handwritten and electronic clinical records. Analyzed 
variables included patient demographic characteristics (gender, age, ethnicity and body weight), 
comorbidities [presence of hypertension, diabetes mellitus, cardiovascular disease (CVD), chronic 
obstructive pulmonary disease (COPD), cirrhosis and/or malignancy], primary diagnosis on 
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admission (medical vs. surgical), source of infection, biochemical parameters [pH, serum lactates, 
serum hemoglobin and serum albumin at ICU admission, as well as daily serum creatinine (SCr)], 
urine output (UO), disease severity score according to the Simplified Acute Physiologic Score (SAPS) 
II (Le Gall, Lemeshow, & Saulnier, 1993) and as determined by the worst variables recorded during 
the first 24 h, fluid balance, vasopressor use, need for mechanical ventilation and requirement of 
renal replacement therapy. Hypertension was diagnosed according to the seventh report of the Joint 
National Committee (Chobanian et al., 2003) and diabetes mellitus was diagnosed according to the 
American Diabetes Association criteria (2009). CVD was considered as present whenever a history of 
chronic heart failure of any etiology, cardiac ischemic disease, cerebrovascular disease and/or pe-
ripheral arterial disease was documented and COPD included both emphysema and chronic bronchi-
tis. For CVD and COPD, a previous diagnosis on clinical records was considered adequate for the 
confirmation of this diagnosis. The outcome measure was development of AKI.
The KDIGO classification based on both serum creatinine (SCr) and urine output (UO) criteria was 
used to diagnose and classify patients developing AKI within the first week of ICU hospitalization 
(Lameire, Kellum, & Aspelin, 2012). The criteria that culminated in the worst classification was used 
and the maximum KDIGO stage was recorded. SCr is determined at least once daily and UO is re-
corded on an hourly basis for all patients as per protocol in this ICU. For determination of baseline 
SCr values, pre-admission SCr (SCr within the previous three months) was considered and accepted. 
When these values were unavailable, baseline SCr was estimated from the MDRD equation 
(Manjunath, Sarnak, & Levey, 2001), considering the lower limit of a normal baseline glomerular fil-
tration rate (GFR) of 75 mL/min/1.73 m2. Hourly urine output was registered and available for all 
patients, and the urine output value within 6 h periods was considered to identify and classify AKI, 
as proposed.
2.3. Statistical methods
Categorical variables were reported as the total number and percentage of cases for each category, 
while continuous variables were presented as the mean ± standard deviation. Student’s t-test was 
used to compare normally distributed continuous variables, Mann–Whitney U test was used to com-
pare non-normally distributed continuous variables and chi-square test was used to compare cate-
gorical variables. Univariate and multivariate logistic regression analysis was applied to determine 
risk factors for AKI. Only variables with statistical significance in the univariate analysis were in-
cluded in the multivariate analysis model (enter model). Data were expressed as odds ratios (ORs) 
with 95% confidence intervals (CIs). Model fit was assessed by the goodness-of-fit test and discrimi-
nation was assessed by the area under the receiver operating characteristic (AUROC) curve. Statistical 
significance was defined as a p-value < 0.05. Statistical analysis was performed with the statistical 
software package SPSS for windows (version 21.0; SPSS, Chicago, IL, USA).
3. Results
3.1. Participants
After investigation of the ICU patient admission register, 723 patients were included as potentially 
eligible. Of these, 266 were excluded based on the following criteria: 122 had stage 5 CKD on regular 
renal replacement therapy and 144 had been hospitalized for a period less than 48 h. No patients 
required renal replacement therapy in the week foregoing ICU admission. Hence, we examined a fi-
nal cohort of 457 patients. Baseline characteristics of the selected population, and the clinical and 
demographic characteristics of the patients according to AKI development are shown in Table 1.
Pre-admission SCr was obtainable in 185 patients (40.6%) and in the outstanding cases 
[n = 272(59.4%)] estimation using the MDRD formula, assuming a baseline estimated GFR of 75 mL/
min/1.73 m2, was required. AKI occurred in 87.5% of patients with a maximum KDIGO category 
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(19.5% with stage 1, 22.6% with stage 2 and 45.4% with stage 3). Median time to AKI development 
was 2 days (1 to 8 days). One-hundred and eight patients (23.7%) underwent renal replacement 
therapy (8.3% intermittent hemodialysis, 76% continuous venovenous hemodiafiltration, and 15.7% 
both). Three hundred and sixteen patients (69.8%) had septic shock criteria. Patients diagnosed with 
AKI were more likely to have significantly higher SAPS II values (p = 0.002) and to require 
Table 1. Demographic and clinical characteristics of patients according to the baseline 
characteristics and the development of acute kidney injury
Characteristic Value KDIGO classification
No AKI (n = 57) AKI (n = 399) p value
Age (year) 64.1 ± 16.4 64.1 ± 17.4 64.1 ± 16.0 0.994
Gender (Male)—n (%) 264 (57.9) 35 (61.4) 229 (57.4) 0.566
Race (Caucasian)—n (%) 433 (94.7) 54 (94.7) 379 (95.0) 0.936
Weight (kg)—mean ± SD 76.2 ± 18.2 70.9 ± 14.3 77.0 ± 18.6 0.019
Co-morbidities—n (%)
 Hypertension—n (%) 212 (46.5) 30 (50.2) 182 (45.6) 0.320
 Diabetes—n (%) 103 (22.6) 15 (26.3) 88 (22.1) 0.472
 CVD—n (%) 125 (27.4) 14 (24.6) 111 (27.8) 0.606
 COPD—n (%) 38 (8.3) 5 (8.8) 33 (8.3) 0.898
 Cirrhosis—n (%) 18 (3.9) 1 (1.8) 17 (4.3) 0.363
 Neoplasia—n (%) 109 (23.9) 13 (22.8) 96 (24.1) 0.836
Medical admission—n (%) 253 (55.5) 31 (54.4) 222 (55.6) 0.859
Infection source—n (%)
 Abdominal—n (%) 187 (41.0) 19 (33.3) 168 (42.1) 0.208
 Respiratory—n (%) 138 (30.3) 16 (28.3) 122 (30.6) 0.700
 Kidney—n (%) 57 (12.5) 14 (24.6) 43 (10.8) 0.003
 Skin—n (%) 34 (7.5) 2 (3.5) 32 (8.0) 0.225
 Others—n (%) 26 (5.7) 6 (10.5) 20 (5.0) 0.093
 Unknown—n (%) 14 (3.1) 0 (0.0) 14 (3.5) 0.151
SAPS II—mean ± SD 49.4 ± 17.3 42.8 ± 15.6 50.4 ± 17.3 0.002
Baseline SCr (mg/dl)*—mean ± SD 1.3 ± 0.6 1.4 ± 0.7 1.3 ± 0.6 0.185
Lactates (mg/dl)—mean ± SD 28.6 ± 24.5 18.6 ± 9.3 29.9 ± 25.7 0.001
pH—mean ± SD 7.32 ± 0.1 7.35 ± 0.1 7.32 ± 0.1 0.011
Hemoglobin (g/dl)—mean ± SD 10.4 ± 2.0 10.0 ± 1.7 10.5 ± 2.0 0.078
Serum albumin (g/dl)—mean ± SD 1.9 ± 0.6 2.1 ± 0.6 1.9 ± 0.6 0.003
Mechanical ventilation—n (%) 350 (76.6) 41 (8.9) 309 (77.4) 0.357
Vasopressors—n (%) 316 (69.4%) 26 (45.6) 290 (72.7) <0.001
Fluid balance (liters)—mean ± SD 4.5 ± 5.7 4.6 ± 5.5 3.6 ± 6.9 0.18
RRT—n (%) 108 (23.7) 108 (27.1)
LOS in hospital (days)—mean ± SD 37.1 ± 39.4 39.5 ± 44.8 36.7 ± 38.6 0.625
LOS in ICU (days)—mean ± SD 10.0 ± 10.0 9.8 ± 10.3 10.0 ± 10.0 0.881
ICU mortality—n (%) 108 (23.7) 7 (12.3) 101 (25.3) 0.030
In-hospital mortality—n (%) 153 (33.6) 10 (17.5) 143 (87.5) 0.006
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vasopressors (p < 0.001) when compared to patients who did not develop AKI. Lower serum pH and 
albumin values were also more frequently found among AKI patients (p = 0.011 and p = 0.003, 
respectively). AKI developed more frequently in patients with urinary tract infections (p = 0.003).
3.2. Serum lactates and AKI
Serum lactates were higher among patients developing AKI as compared with non-AKI patients 
(mmol/L 29.9 ± 25.7 vs. 18.6 ± 9.3, p = 0.001; unadjusted OR 1.04 (95% CI 1.02–1.07), p = 0.001) 
(Table 1), and they were progressively higher according to increasing AKI severity (stage 1, 
24.5 ± 18.7; stage 2, 25.5 ± 16.9; stage 3, 34.6 ± 30.7; p = 0.001). In multivariate analysis, serum lac-
tates at ICU admission were independently associated with the occurrence of AKI (adjusted OR 1.03 
(95% CI 1.01–1.06), p = 0.024) (Table 2). The ROC curve of AKI for in-hospital mortality was 0.645 
(95% CI 0.577–0.713); p < 0.001).
Table 2. Univariate and multivariate analysis of factors associated with acute kidney injury
AKI
Unadjusted OR (95% 
CI)
p-value Adjusted OR (95% CI) p-value
Demographics
Age 1.00 (0.98–1.02) 0.094
Male 0.85 (0.48–1.50) 0.567
Caucasian 1.053 (0.30–3.66) 0.936
Body weight 1.02 (1.01–1.04) 0.019 1.02 (1.01–1.04) 0.037
Co-morbidities
Hypertension 0.76 (0.43–1.32) 0.321
Diabetes 0.79 (0.42–1.50) 0.473
CVD 1.18 (0.62–2.25) 0.606
COPD 0.94 (0.35–2.51) 0.898
Cirrhosis 2.492 (0.33–19.09) 0.379
Neoplasia 1.04 (0.75–1.44) 0.836
Medical admission 1.05 (0.60–1.84) 0.859
Infection source
Abdominal 1.45 (0.81–2.61) 0.210
Respiratory 1.13 (0.61–2.09) 0.700
Kidney 0.37 (0.19–0.73) 0.004 0.43 (0.20–0.91) 0.028
Skin 2.40 (0.56–10.29) 0.239
Others 0.45 (0.17–1.17 0.101
SAPS II 1.03 (1.01–1.05) 0.002 1.01 (0.90–1.03) 0.690
Baseline SCr 0.76 (0.50–1.15) 0.188
pH 0.02 (0.01–0.4) 0.012 0.11 (0.03–3.90) 0.226
Lactates 1.04 (1.02–1.07) 0.001 1.03 (1.01–1.06) 0.024
Hemoglobin 1.14 (0.99–1.32) 0.078
Serum albumin 0.51 (0.33–0.81) 0.004 0.70 (0.43–1.15) 0.162
Mechanical ventilation 1.34 (0.72–2.50) 0.358
Septic shock (need of 
vasopressors)
3.17 (1.80–5.59) 0.0001 2.39 (1.23–4.64) 0.010
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4. Discussion
In this retrospective study including 457 critically ill patients with sepsis, we established that serum 
lactates at ICU admission were independently associated with AKI.
Previous studies on septic patients have only investigated the impact of lactate and its change on 
mortality (Casserly et al., 2015). Nonetheless, considering that lactate is a sensitive biomarker of not 
only global but also regional hypoperfusion (Jones & Puskarich, 2009), serum lactate can theoreti-
cally be used as a marker of ongoing hypoperfusion that may eventually contribute to ongoing de-
velopment of AKI. As far as we know, lactate has never been studied for its independent association 
with AKI in septic patients. In fact, although higher levels of serum lactates have been reported to 
occur in patients with AKI as compared with non-AKI patients, an independent association of serum 
lactates with AKI has not yet been described. In an observational cohort study, Plataki and col-
leagues aimed to evaluate predictors of AKI (defined by RIFLE based on SCr and urine output) by 
enrolling 390 patients with septic shock. Although they found higher levels of serum lactate in AKI 
patients compared to those patients not developing AKI (2.3 vs. 1.9, mmoL, p = 0.01), serum lactates 
were not independently associated with AKI in this cohort (Plataki et al., 2011).
Recent studies on AKI in patients undergoing cardiac surgery have also established an association 
between serum lactates and risk of AKI (Lopez-Delgado et al., 2013; Zhang & Ni, 2015). However, in 
this specific setting, serum lactates can be influenced by various factors during and after cardiopul-
monary bypass. During cardiopulmonary bypass, hyperlactatemia may arise from: (1) administra-
tion of Ringer’s lactate solution (priming pump); (2) low-perfusion pressure secondary to distributive 
shock; and (3) type-B hyperlactatemia (frequently associated with hyperglycemia). Inversely, the 
majority of the causes of hyperlactatemia resulting from an inadequate oxygen supply can be iden-
tified following the cardiopulmonary bypass phase, including left/right pump dysfunction and/or 
distributive shock (Zhang & Ni, 2015). The pathogenesis of AKI in septic patients is, however, distinct 
from that of AKI in patients undergoing cardiac surgery. While low renal blood flow during cardiopul-
monary bypass in cardiac surgery, with consequent renal oxygenation impairment may eventually 
trigger renal failure, and the production and release of several pro inflammatory mediators, such as 
interleukins, TNFα and other metabolites can lead to membrane damage of the renal tubular epithe-
lium (Friedrich et al., 2017; Wanderer & Rathmell, 2017), sepsis-induced AKI can occur in the setting 
of normal or even increased renal blood flow. In sepsis, AKI is characterized by heterogeneous areas 
of colocalized listless peritubular blood flow and tubular epithelial cell oxidative stress, rather than 
by acute tubular necrosis or apoptosis. Evidence has also revealed that inflammation, diffuse micro-
circulatory flow irregularities and cell bioenergetic adaptive responses to injury are vital pathophysi-
ologic mechanisms that may explain the development of sepsis-induced AKI (Gomez et al., 2014). 
Epithelial cells of the kidney may have the ability to respond to initial inflammatory injury by activat-
ing energy regulatory pathways as a means to preserve energy balance, and limit oxidative damage 
from dysfunctional mitochondria (Gómez, Jin, & Kellum, 2015).
The causes of hyperlactacidemia in sepsis are also different from those in cardiac surgery patients. 
Epinephrine-dependent stimulation of the β2-adrenoceptor increases the glycolytic flux both direct-
ly and indirectly by enhancing activity of the sarcolemmal Na+, K+-ATPase (which consumes great 
quantities of ATP)in the hyperdynamic stage of sepsis (Levy, Desebbe, Montemont, & Gibot, 2008). In 
inflammatory states, aerobic glycolysis can also be driven by cytokine-dependent stimulation of cel-
lular glucose uptake (Taylor, Faragher, & Evanson, 1992). In global or localized tissue hypoxia, lac-
tate is overproduced and underutilized as a result of compromised mitochondrial oxidation. Even if 
systemic oxygen delivery is not low enough to induce generalized hypoxia, microcirculatory dysfunc-
tion can cause regional tissue hypoxia and hyperlactatemia (Ince, 2005; Kraut & Madias, 2014). 
Hyperlactatemia can also result from aerobic glycolysis, representing stimulated glycolysis that is 
contingent on other factors besides tissue hypoxia. Activated in response to stress, aerobic glycolysis 
is an effective, albeit inefficient, mechanism for the rapid generation of ATP (Levy et al., 2008). 
Additionally, there are many sources of lactate in sepsis aside from hypoperfusion-induced tissue 
hypoxia. For example, non-hypoxemic causes include catecholamine-driven accelerated glycolytic 
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flux, stimulation of sodium-potassium adenosine triphosphatase pump activity, and inhibition of 
pyruvate dehydrogenase, along with decreased lactate metabolism by the liver (Garcia-Alvarez, 
Marik, & Bellomo, 2014).
In the present study, serum lactate was independently associated with AKI diagnosed within the 
first two days of ICU stay. Taking this into consideration, we hypothesize that hyperlactacidemia can 
be an early marker of the underlying renal lesion conditioning a reduced renal uptake of lactate and 
metabolization or can appear as an adaptive response to conserve energy balance as a result of limi-
tation of oxidative damage due to dysfunctional mitochondria. It is important to recall that the na-
tive kidney is second only to the liver in eliminating lactate from the circulation and metabolizing it 
(Bellomo, 2002).
In the present study, some limitations have to be recognized. Firstly, the single-centre and retro-
spective nature of the study with a small cohort of patients may compromise, at least in part, the 
results of our study. Secondly, other factors contributing to elevation of serum lactates, such as 
presence of liver failure and medications (i.e. metformin) were not evaluated. Third, the percentage 
of caucasian patients could limit the generalization of this study.
Regardless of these limitations, our study has numerous notable strengths. To the best of our 
knowledge, this is the first study evaluating the association between lactate and AKI in septic pa-
tients in an ICU. Moreover, despite the retrospective nature of the study, most of the studied varia-
bles were registered as part of routine clinical practice on a daily basis and made accessible for 
analysis.
5. Conclusion
In a cohort of critically ill septic patients, serum lactates at ICU admission were independently as-
sociated with AKI occurrence.
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